Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
41 Cards in this Set
- Front
- Back
adults over ___ should be screened every ___ for DM
|
45
3 years |
|
DM is diagnosed if one of ___ (3) is present
|
2 FPG measurements >=126
1 FPG measurement >=200 GTT exceeds 200 within 2 h |
|
initial DM2 drug regimen: ___
or ___, if obese |
glipizide 5mg qd
metformin 500 mg qd |
|
HbA1c should be measured every ___
goal is ___ |
6m
<7% |
|
DM1 is ___% of DM
|
5-10%
|
|
glipizide is a ___ drug
|
sulfonylurea
|
|
T/F: urine glucose levels are important in screening
|
false
|
|
T/F: urine ketones levels are important in management
|
true
|
|
___% of DM2 pts are obese
|
80
|
|
recommended exercise regime:
aerobics ___ per week for ___ minutes |
3--5
30--45 |
|
6 oral hypoglycemic families
|
sulfonulurea
a-glucosidase inhibitor biguanide non-sulfonylurea secretagogue thiazolidinedione DPP-4 inhibitor |
|
metformin can cause ___ but this is rare
because of this, it's contraindicated in ___ |
lactic acidosis
renal failure |
|
metformin causes less ___ than other hypoglycemic agents
|
weight gain
|
|
4 common metformin SEs
|
nausea
vomiting diarrhea metallic taste in mouth |
|
1 a-glucosidase inhibitor
|
acarbose
|
|
2 TZDs
|
pioglitazone
rosiglitazone |
|
___ must be monitored in pts taking TZDs
|
LFTs
|
|
LFT regime for TZD-taking patients (2)
|
every 2m for first year
periodically thereafter |
|
DPP-4 inhibitors work via ___
|
inhibiting deactivation of incretin hormones
|
|
2 incretins
|
GLP-1
GIP (gastric inhibitory peptide) |
|
1 DPP-4 inhibitor
|
sitagliptin
|
|
2 indications for insulin in DM2
|
in addition to oral hypoglycemics
as initial tx |
|
insulin is indicated as initial tx for DM2 patients if ___
|
glucose >400
young, non-obese, symptomatic |
|
___ insulin is good at controlling postprandial sugar
|
short-acting
|
|
long acting insulin is associated with low rates of ___ (2)
|
hypoglycemia
weight gain |
|
3 rapid acting insulins
|
lispro
aspart inhaled |
|
rapid acting insulins have onset in ___ hrs,
peak at ___ hrs, and act for ___ hrs |
0.2--0.5
0.5--1 3--5 |
|
1 short-acting insulin
|
regular
|
|
short acting insulins have onset in ___ hrs,
peak at ___ hrs, and act for ___ hrs |
0.5--1
2--3 4--12 |
|
1 intermediate-acting insulin
|
NPH
|
|
intermediate acting insulins have onset in ___ hrs,
peak at ___ hrs, and act for ___ hrs |
1--2
4--5 10--20 |
|
2 long-acting insulins
|
glargine
detemir |
|
long acting insulins have onset in ___ hrs,
peak at ___ hrs, and act for ___ hrs |
1--2
no peak 24 |
|
normal insulin regimen for DM1 pts:
either ___ or ___ |
split regimen
glargine + preprandial rapid-acting |
|
split regimen means injections of ___ at ___ and ___
|
regular/NPH mix
before breakfast before supper |
|
2 non-insulin injectables
only ___ can be used in DM1 |
exenatide
pramlintide pramlindtide |
|
exenatide is a ___
it is indicated for ___ |
incretin mimetic
patients who failed metformin mono- or combination tx |
|
pramlintide is a ___
it does ___ |
amylin analog
glucagon inhibition appetite reduction |
|
6 recommended values for DM pts
|
HbA1C<7%
80<FPG<120 BP<130/85 LDL<100 HDL>40 TAG<150 |
|
3 vaccines mandated for DM pts
|
flu
S. pneumoniae tetanus |
|
DM pts should get S. pneumoniae vaccine every ___
and tetanus every ___ |
5--7 years
10 years |